You're reading the free version. Trader adds the live tape and alerts.
Start tracking
REGN Exercise Disclosure
Fenimore Christopher R. · SEC Form 4 · Filed Aug 20, 2026
Exercise
Calculated transaction value
$0
Fenimore Christopher R. EVP Finance CFO
REGN
Transaction date
Aug 18, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed 2 days later
REGN daily price context
Close on/before transaction
$810.24
Aug 18, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (right to buy) on Common Stock
- Quantity / price
- 6,283 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001697422-26-000002
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$6.14M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | Disposition | Aug 18, 2026 | $3.74M |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Aug 18, 2026 | $2.4M |
| Regeneron Pharmaceuticals, Inc. REGN Current | Exercise | Aug 18, 2026 | $0 |